TUG1 Suppression Boosts Immunity and Lenvatinib in Liver Cancer
Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide, with limited therapeutic options and a poor prognosis that continues to challenge clinicians and researchers...














